Chardan Capital Has Negative Outlook of COYA FY2025 Earnings
Coya Therapeutics, Inc. (NASDAQ:COYA – Free Report) – Investment analysts at Chardan Capital reduced their FY2025 earnings per share (EPS) estimates for shares of Coya Therapeutics in a report released on Wednesday, May 14th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings of ($1.57) per share for the year, down […]
More Stories
Cybersecurity Researchers Link North Korea to $6.4 Billion Binance Hack
By Ryan Morgan Private blockchain analysis companies TRM Labs and Chainalysis have both assessed that North Korean state-backed hackers were...
US Approves Possible $2.1 Billion Sale of 500 Patriot Missiles to Ukraine
By Kimberly Hayek The State Department announced Oct. 30 that it has approved a possible sale of 500 Patriot Advanced...
Who is Timothy Busfield? Cases, Movies, Shows, and Wife
After spending several years under the allegation of child abuse charges, a New Mexico judge has finally issued a judgment....
Economic Momentum Builds as New Figures Beat Expectations
By Andrew Morand and Emel Akan The U.S. economy may be doing more than weathering recent shocks. A fresh batch...
Polish President Aborts Senegal Trip as Protests Erupt Over Court Chief’s Suspension
By Aldgra Fredly Polish President Karol Nawrocki turned back his plane on Oct. 30 while en route to Senegal after...
Judge Bars DOJ From Threatening Election Staff With Criminal Prosecution Over Ballots Processing
By Aldgra Fredly A federal judge barred the Department of Justice (DOJ) from threatening state and local election officials with...